Literature DB >> 25253227

American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease.

W Timothy Garvey1, Alan J Garber2, Jeffrey I Mechanick3, George A Bray4, Samuel Dagogo-Jack5, Daniel Einhorn6, George Grunberger7, Yehuda Handelsman8, Charles H Hennekens9, Daniel L Hurley10, Janet McGill11, Pasquale Palumbo12, Guillermo Umpierrez13.   

Abstract

Entities:  

Year:  2014        PMID： 25253227      PMCID： PMC4962331          DOI： 10.4158/EP14280.PS

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  8 in total

1.  Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society.

Authors:  J Michael Gonzalez-Campoy; Sachiko T St Jeor; Kristin Castorino; Ayesha Ebrahim; Dan Hurley; Lois Jovanovic; Jeffrey I Mechanick; Steven M Petak; Yi-Hao Yu; Kristina A Harris; Penny Kris-Etherton; Robert Kushner; Maureen Molini-Blandford; Quang T Nguyen; Raymond Plodkowski; David B Sarwer; Karmella T Thomas
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

Review 2.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

3.  American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine.

Authors:  Jeffrey I Mechanick; Alan J Garber; Yehuda Handelsman; W Timothy Garvey
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

Review 4.  New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach.

Authors:  W Timothy Garvey
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

5.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

6.  American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

Authors:  Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Michael B Davidson; Daniel Einhorn; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez; Michael H Davidson
Journal:  Endocr Pract       Date:  2013 May-Jun       Impact factor: 3.443

7.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

8.  The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.

Authors:  Fangjian Guo; Douglas R Moellering; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2013-09-05       Impact factor: 5.002
  8 in total
  30 in total

1.  Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies.

Authors:  Caroline M Apovian; W Timothy Garvey; Donna H Ryan
Journal:  Obesity (Silver Spring)       Date:  2015-07       Impact factor: 5.002

2.  Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Authors:  A Goday; I Barneto; J M García-Almeida; A Blasco; A Lecube; C Grávalos; P Martínez de Icaya; R de las Peñas; S Monereo; L Vázquez; J E Palacio; P Pérez-Segura
Journal:  Clin Transl Oncol       Date:  2015-06-03       Impact factor: 3.405

3.  Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea.

Authors:  In Cheol Hwang; Jeong Hun Bae; Joon Mo Kim
Journal:  Eye (Lond)       Date:  2019-02-13       Impact factor: 3.775

4.  A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis.

Authors:  Olabola Awosika; Misty G Eleryan; Monica Rengifo-Pardo; Lindsay Doherty; Lisa W Martin; Alison Ehrlich
Journal:  J Clin Aesthet Dermatol       Date:  2018-06-01

Review 5.  Obesity as a Disease: Current Policies and Implications for the Future.

Authors:  Scott Kahan; Tracy Zvenyach
Journal:  Curr Obes Rep       Date:  2016-06

6.  Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults.

Authors:  Fangjian Guo; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2015-12-31       Impact factor: 5.002

Review 7.  Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.

Authors:  J Grams; W Timothy Garvey
Journal:  Curr Obes Rep       Date:  2015-06

Review 8.  Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.

Authors:  W Timothy Garvey; Jeffrey I Mechanick
Journal:  Obesity (Silver Spring)       Date:  2020-03       Impact factor: 5.002

9.  Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes.

Authors:  Fangjian Guo; W Timothy Garvey
Journal:  J Clin Endocrinol Metab       Date:  2015-08-04       Impact factor: 5.958

Review 10.  Obstructive Sleep Apnea as a Cardiovascular Risk Factor-Beyond CPAP.

Authors:  Joshua M Bock; Soumya Vungarala; Shahid Karim; Virend K Somers
Journal:  Can J Cardiol       Date:  2021-02-19       Impact factor: 5.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.